Floatz logo

Sofosbuvir

Beta Thalassemia Major

Ain Shams UniversitySmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

32 Active assets in the Beta Thalassemia Major cohort.

Asset / SponsorPhaseRating
Deferasirox
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB
Deferiprone
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB
Hydroxyurea
Bahria University
Phase 4BBB
DESFERRIOXAMINE B
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB
TACROLIMUS
M.D. Anderson Cancer Center
Phase 4BBB

View all 50 →

Same molecule, other indications

Sofosbuvir is also rated in:

hepatitis C virus infectionDormant
A
Indicative ·
82 / 100
View asset →
chronic hepatitis C virus infectionDormant
A
Indicative ·
81 / 100
View asset →
cirrhosis of liverDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →